Portfolio company
DEEP Measures
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company provides a platform for developing and validating digital biomarkers and endpoints for pharmaceutical companies and clinical research organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
HOME REPORTED OUTCOMES
This company provides a mobile platform for patients and caregivers to track health data for clinical research and personalised care.
HumanFirst
This company provides a platform for life science organisations to evaluate and deploy digital measures for clinical trials and remote patient monitoring.
Aparito
This company provides a software platform for remote patient monitoring and clinical trial data collection for pharmaceutical, biotech and research organisations.
HealthMode
This company develops an artificial intelligence platform for automated patient monitoring and digital measurement tools to support clinical researchers and drug developers.
Heartbeat Medical
This company develops a digital platform to collect and analyse patient-reported outcomes for hospitals, pharmaceutical firms, and medical device manufacturers.
Deep Origin
This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
Koios Care
This digital medicine company develops an AI platform that monitors Parkinson’s disease symptoms using wearable devices for healthcare providers and pharmaceutical researchers.
